Providence Health & Services

This early-phase trial tested a drug called MEDI0562, which aims to boost the immune system's ability to fight cancer. It was given to 13 patients with advanced head and neck cancer or melanoma before their surgery. The main goal was to see if the drug safely activates the immune…

This study tested a shorter radiation course combined with TASOX chemotherapy in 13 people with stage II/III rectal cancer. The goal was to shrink tumors before surgery. Results showed the treatment was safe and helped reduce tumor stage, allowing for complete removal. This appro…

This early-phase study tested an experimental immune therapy called IRX-2 in 16 people with early-stage breast cancer, including triple-negative breast cancer. The goal was to see if giving IRX-2 before standard chemotherapy is safe and whether it boosts the immune system's attac…

This study tested whether wearing special cold caps (Penguin caps) during chemotherapy can prevent or reduce hair loss in people with early-stage breast cancer. Twelve participants used the caps while receiving one of four common chemo regimens. The goal was to see if at least ha…